Cargando…
Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods
The performance of the Xpert© MTB/RIF and MTBDRplus assays for the detection of rifampicin resistant Mycobacterium tuberculosis was compared to culture-based drug susceptibility testing in 30 specimens with rifampicin-resistant and rifampicin-indeterminate Xpert MTB/RIF results collected between Mar...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295983/ https://www.ncbi.nlm.nih.gov/pubmed/30568904 http://dx.doi.org/10.4102/ajlm.v7i2.806 |
_version_ | 1783380952561483776 |
---|---|
author | Mwanza, Winnie Milimo, Deborah Chilufya, Maureen M. Kasese, Nkatya Lengwe, Maina C. Munkondya, Stembiso de Haas, Petra Ayles, Helen Muyoyeta, Monde |
author_facet | Mwanza, Winnie Milimo, Deborah Chilufya, Maureen M. Kasese, Nkatya Lengwe, Maina C. Munkondya, Stembiso de Haas, Petra Ayles, Helen Muyoyeta, Monde |
author_sort | Mwanza, Winnie |
collection | PubMed |
description | The performance of the Xpert© MTB/RIF and MTBDRplus assays for the detection of rifampicin resistant Mycobacterium tuberculosis was compared to culture-based drug susceptibility testing in 30 specimens with rifampicin-resistant and rifampicin-indeterminate Xpert MTB/RIF results collected between March 2012 and March 2014. Xpert MTB/RIF and MTBDRplus were 100% sensitive and 100% concordant for rifampicin resistance detection, but 3 of 13 samples (23%) positive for rifampicin resistance on Xpert MTB/RIF and MTBDRplus were negative for rifampicin resistance on mycobacteria growth indicator tube drug susceptibility testing. Specificity was 72% for Xpert MTB/RIF and 80% for MTBDRplus. Positive predictive value for Xpert MTB/RIF for multidrug resistant tuberculosis was 47.8% for new patients and 77.8% for previously treated patients; negative predictive value was 100% for both new and previously treated patients. The discordant rifampicin resistance test results indicate a need to fully characterise circulating rifampicin resistant Mycobacterium tuberculosis strains in Zambia and to inform the development of guidelines for decision-making in relation to diagnosis of drug-resistant tuberculosis. |
format | Online Article Text |
id | pubmed-6295983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | AOSIS |
record_format | MEDLINE/PubMed |
spelling | pubmed-62959832018-12-19 Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods Mwanza, Winnie Milimo, Deborah Chilufya, Maureen M. Kasese, Nkatya Lengwe, Maina C. Munkondya, Stembiso de Haas, Petra Ayles, Helen Muyoyeta, Monde Afr J Lab Med Brief Report The performance of the Xpert© MTB/RIF and MTBDRplus assays for the detection of rifampicin resistant Mycobacterium tuberculosis was compared to culture-based drug susceptibility testing in 30 specimens with rifampicin-resistant and rifampicin-indeterminate Xpert MTB/RIF results collected between March 2012 and March 2014. Xpert MTB/RIF and MTBDRplus were 100% sensitive and 100% concordant for rifampicin resistance detection, but 3 of 13 samples (23%) positive for rifampicin resistance on Xpert MTB/RIF and MTBDRplus were negative for rifampicin resistance on mycobacteria growth indicator tube drug susceptibility testing. Specificity was 72% for Xpert MTB/RIF and 80% for MTBDRplus. Positive predictive value for Xpert MTB/RIF for multidrug resistant tuberculosis was 47.8% for new patients and 77.8% for previously treated patients; negative predictive value was 100% for both new and previously treated patients. The discordant rifampicin resistance test results indicate a need to fully characterise circulating rifampicin resistant Mycobacterium tuberculosis strains in Zambia and to inform the development of guidelines for decision-making in relation to diagnosis of drug-resistant tuberculosis. AOSIS 2018-12-06 /pmc/articles/PMC6295983/ /pubmed/30568904 http://dx.doi.org/10.4102/ajlm.v7i2.806 Text en © 2018. The Authors https://creativecommons.org/licenses/by/4.0/ Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. |
spellingShingle | Brief Report Mwanza, Winnie Milimo, Deborah Chilufya, Maureen M. Kasese, Nkatya Lengwe, Maina C. Munkondya, Stembiso de Haas, Petra Ayles, Helen Muyoyeta, Monde Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods |
title | Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods |
title_full | Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods |
title_fullStr | Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods |
title_full_unstemmed | Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods |
title_short | Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods |
title_sort | diagnosis of rifampicin-resistant tuberculosis: discordant results by diagnostic methods |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295983/ https://www.ncbi.nlm.nih.gov/pubmed/30568904 http://dx.doi.org/10.4102/ajlm.v7i2.806 |
work_keys_str_mv | AT mwanzawinnie diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods AT milimodeborah diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods AT chilufyamaureenm diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods AT kasesenkatya diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods AT lengwemainac diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods AT munkondyastembiso diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods AT dehaaspetra diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods AT ayleshelen diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods AT muyoyetamonde diagnosisofrifampicinresistanttuberculosisdiscordantresultsbydiagnosticmethods |